Central Banks Demand More Gold - This $1 Firm Could Supply It

This tiny company is currently sitting on one of America's largest deposits of gold... land that was hidden away from the public for over 60 years. With Central Banks demanding gold to combat inflation - miners like this one show huge potential for investors

ALNY
Alnylam Pharmaceuticals Inc
NASDAQ
470.27
Open 469.19 Prev Close 469.36
High 485.28 Low 467.50
Volume 1,475,354 Volume (Avg) 1,167
52 Week High 485.28 52 Week Low 205.87
Market Cap 61.6B PE Ratio

About Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference. It offers ONPATTRO and AMVUTTRA for hereditary transthyretin-mediated amyloidosis; GIVLAARI for acute hepatic porphyria; OXLUMO for primary hyperoxaluria type 1; and Leqvio for hypercholesterolemia. It also develops vutrisiran, which is in phase III clinical trial for transthyretin amyloidosis (ATTR) with cardiomyopathy; Nucresiran that is in phase I clinical trial for ATTR amyloidosis; Fitusiran, which is in phase III clinical trial for hemophilia; cemdisiran that is in phase III clinical trial for Myasthenia Gravis and paroxysmal nocturnal hemoglobinuria, and geographic atrophy; and ALN-6400, which is in phase I clinical trial for bleeding disorders. In addition, the company is also developing Zilebesiran, which is in phase II clinical trial for hypertension; Rapirosiran that is in phase II clinical trial for Metabolic dysfunction-associated steatohepatitis; ALN-4324, which is in phase I clinical trial for type 2 diabetes mellitus; ALN-PNP that is in phase I clinical trial for non-alcoholic fatty liver disease; ALN-APOC3, which is in phase I clinical trial for dyslipidemia; Mivelsiran that is in phase II clinical trial for cerebral amyloid angiopathy, and phase I clinical trial for Alzheimer's disease; and ALN-HTT02 that is in phase I clinical trial for Huntington's disease. Further, it develops ALN-SOD, which is in phase II clinical trial for SOD1 Amyotrophic lateral sclerosis; Elebsiran that is in phase II clinical trial for Hepatitis B and D virus infections; ALN-BCAT that is in phase I clinical trial for hepatocellular carcinoma; and ALN-ANG3. It has collaborations with Regeneron Pharmaceuticals, Inc.; Roche Holding AG; Regeneron Pharmaceuticals, Inc.; Sanofi S.A.; Novartis AG; PeptiDream, Inc; Dicerna Pharmaceuticals, Inc.; and Ionis Pharmaceuticals, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.

General

NameAlnylam Pharmaceuticals Inc
TickerALNY
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees2,230

Highlights

Analyst Target474.92
Market Cap61,642,500,000
PEG Ratio-0.49
EBITDA-123,687,000

Share Stats

Shares Outstanding130,980,000
Shares Float125,500,000
Shares Short3,510,000
Insider Holdings382%
Institution Holdings99.26%

Highlights

Analyst Target474.92
Market Cap61,642,500,000
PEG Ratio-0.49
EBITDA-123,687,000

Valuation

Forward PE46.51
Price/Sales (Trailing 12 Mt.)24.99
Price/Book (Most Recent Quarter)241.13

Earnings

Most Popular

Judge temporarily blocks the Trump administration from firing workers during the government shutdown

SAN FRANCISCO (AP) — President Donald Trump’s administration for now must stop firing workers during , a federal judge ordered on Wednesday.

What's Going On With Archer Aviation Stock Wednesday?

Shares of Archer Aviation Inc. (NASDAQ: ACHR) are rising Wednesday after the air mobility company confirmed it won a bid for a portfolio of patents.

Trump's Radical Plans for the Dollar - Ad

The Fed just slashed rates... yet mortgages have already soared higher. Meanwhile, Trump has his own plan for the dollar - a radical upgrade to our currency, already moving more money than Visa and Mastercard combined. Tech investor Eric Wade calls it the "Smart Dollar."

Eli Lilly's Oral Weight Loss Drug Shows Superiority Over Two Approved Drugs

Orforglipron meets key endpoints in Phase 3 trials, showing A1C reduction, weight loss, and cardiovascular benefits for type 2 diabetes.

Cathie Wood, Tom Lee Align On These 10 Stock Picks: Some Might Surprise You

A new ETF from Tom Lee shares 10 stocks in common with Cathie Wood's Ark Funds. A look at the stocks both well-known financial figures like.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

A prolonged US government shutdown could impact your travel plans

If a goes on long enough, it could throw a wrench in travel plans, potentially leading to longer airport wait times, flight delays and even cancellations.

Domino's Growth Outlook Intact Despite Softer Q4 Trends, Analysts Say

Domino's Pizza Inc. (NYSE: DPZ) exceeded expectations and maintained 2025 guidance. TD Cowen and BTIG maintain Buy ratings.

Nvidia CEO Makes First Ever Tesla Announcement - Ad

While Tesla's car sales slump, Nvidia's CEO says Tesla could lead a multi-trillion-dollar AI revolution. He's backing what's being called "Manifested AI" - a 25,000% growth market. And one tiny stock, 168x smaller than Nvidia, could be your way in before the world catches on.

Trump Ally Laura Loomer Turns on Him Over Qatar Military Base Plan, Calls It a 'Betrayal'

Laura Loomer, a staunch supporter of President Donald Trump, has voiced her dissatisfaction with the president's decision to permit a Qatari air force facility in Idaho.

TrueCar (TRUE) Stock Soars On Go-Private Buyout Deal

TrueCar shares are trading higher Wednesday afternoon after the company announced it will be acquired by a founder-led strategic investor group.

Why Are Wall Street Insiders Moving Their Money to This One Asset? - Ad

Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.

LendingTree CEO and founder Doug Lebda dies in ATV accident

NEW YORK (AP) — LendingTree CEO and founder Doug Lebda died in an an all-terrain vehicle accident over the weekend, the online loaning platform said Monday.

October 16: D-Day For The Dollar - Ad

A quiet shift in U.S. law has just authorized private companies to mint a new form of government-authorized money called the "Dollar 2.0"... and the next major mint hits on October 16. Investors who make the right moves before then could make up to 40X by 2032...

Ethereum Crashes To $4,100 As Senate Democrats Take Aim At DeFi

Ethereum (CRYPTO: ETH) is trading near $4,100 on Friday, after a sharp selloff that followed its rejection from $4,700 and renewed fears of U.S.

Why Is Wall Street Moving Their Money Overnight? - Ad

Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.

Costco Wholesale, Concentrix And 3 Stocks To Watch Heading Into Friday

With U.S. stock futures trading mixed this morning on Friday, some of the stocks that may grab investor focus today are as follows:

AST SpaceMobile Stock Surges After Hours Amid BlueBird Satellite Production Update

AST SpaceMobile's stock surged 9.49% in after-hours trading on Tuesday, following news of its upcoming satellite launches.

Could $1 Stock Be Sitting on a Billion-Dollar Discovery? - Ad

This $1 stock has already made its mark with a listing on the prestigious NYSE. Now, it's sitting on prime land in one of America's richest gold districts, with the potential for a billion-dollar discovery. For savvy investors, this may be a $1 "Golden Ticket" to massive returns.

Nebius Vs. Palantir: The AI Infrastructure War At 100x Sales

Wall Street's AI mania has sparked a battle between Nebius (NBIS) and Palantir (PLTR) as investors question where the true value of AI lies.

NIO Stock Soars Past 52-Week High After Record Deliveries

NIO stock rises on strong September and Q3 deliveries, reaching record numbers and surpassing 52-week high.

Elon's New Device Could Launch Biggest IPO of the Decade - Ad

Elon Musk's new device is being called a "game-changer"-and even the White House is using this tech. Jeff Brown says it could launch Musk's next trillion-dollar company and make early investors rich. You can claim a stake now for as little as $500.

$1000 Invested In Alnylam Pharmaceuticals 5 Years Ago Would Be Worth This Much Today

Alnylam Pharmaceuticals (NASDAQ: ALNY) has outperformed the market over the past 5 years by 10.45% on an annualized basis producing an average annual return of 25.22%. Currently, Alnylam Pharmaceuticals has a market capitalization of $57.78 billion.

Kevin O'Leary Says Gen Z Is 'Rewriting The Playbook' Of Money And Love, The Shark Is Telling His Students To Do This By The Third Date

Gen Z is changing the rules of money & relationships. They're open to co-buying homes, pooling resources & discussing finances earlier. Kevin O'Leary urges couples to talk about credit & goals by the 3rd date, saying it strengthens partnerships. Co-buying is gaining traction as a way to overcome the affordability hurdle. However, it requires planning to avoid risks. Gen Z also values financial responsibility & is willing to share ownership to get into the housing market.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Central Banks Demand More Gold - This $1 Firm Could Supply It - Ad

This tiny company is currently sitting on one of America's largest deposits of gold... land that was hidden away from the public for over 60 years. With Central Banks demanding gold to combat inflation - miners like this one show huge potential for investors

BHP Hedges China Risks With Olympic Dam Copper Investment

BHP invests over $556 million in copper projects at Olympic Dam, South Australia, to increase production and create jobs.

Ken Griffin Slams Trump's 'Anti-American' And 'Nauseating' Tariff Policy: 'There's Only One Way This Game Ends'

Ken Griffin, a former supporter of President Donald Trump has publicly criticized the President’s tariff policy, calling it “anti-American.”

Trump's Radical Plans for the Dollar - Ad

The Fed just slashed rates... yet mortgages have already soared higher. Meanwhile, Trump has his own plan for the dollar - a radical upgrade to our currency, already moving more money than Visa and Mastercard combined. Tech investor Eric Wade calls it the "Smart Dollar."

HSDT Follows Michael Saylor's Playbook With $530M Solana Bet—Is This The Next MSTR?

One Nasdaq-listed company is betting its future on Solana (CRYPTO: SOL), having amassed a $530 million treasury that echoes Michael Saylor's bold

Macron is set to appoint a new French prime minister in last-ditch move to tackle turmoil

PARIS (AP) — After a week of intense political turmoil, French President is set to appoint a new prime minister Friday in his latest bid to break the political deadlock that has gripped the country for more than a year, as France struggles with mounting economic challenges and ballooning debt.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

12 Health Care Stocks Moving In Monday's Intraday Session

Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands at $5.5 million. Zura Bio (NASDAQ: ZURA) stock moved upwards by 42.94% to $3.44. The company's market cap stands at $156.6 million.

What's Going On With AMD Stock Thursday?

AMD stock cools after surging on OpenAI AI chip news, as Nvidia and Intel make strategic moves in AI semiconductor space.

Nvidia CEO Makes First Ever Tesla Announcement - Ad

While Tesla's car sales slump, Nvidia's CEO says Tesla could lead a multi-trillion-dollar AI revolution. He's backing what's being called "Manifested AI" - a 25,000% growth market. And one tiny stock, 168x smaller than Nvidia, could be your way in before the world catches on.

Mysterious drone flights in NATO airspace have caused alarm across Europe. Here's what we know

BERLIN (AP) — Mysterious drone flights over the airspace of European Union member countries in recent weeks have alarmed the public and elected officials.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright technicaltrading.org
Privacy Policy | Terms of Service